Novosti
Khirurgii
This journal is
indexed in Scopus









Year 2020 Vol. 28 No 3

TRAUMATOLOGY

DOI: https://dx.doi.org/10.18484/2305-0047.2020.3.276   |  

M.V. CHEPELEVA, N.M. KLIUSHIN, A.M. ERMAKOV, E.I. KUZNECOVA

LYMPHOCYTE POPULATIONS IN PATIENTS WITH PERIPROSTHETIC INFECTION OF THE HIP JOINT

National Medical Research Center of Traumatology and Orthopedics Named after Academician G.A. Ilizarov of the Ministry of Health of Russia, Kurgan,
The Russian Federation

Objective. To study the peculiarities of cell-mediated immunity in patients with periprosthetic hip joint infection depending on disease severity and according to the method of surgical intervention, subsequently used.
Methods. The values of cell-mediated immunity were studied at the preoperative stage in patients (n=66) with periprosthetic hip joint infection who were divided into three groups: group I (n=13) debridement of the infected joint with the replacement of the implant modular components; group II (n=36) articulating spacer installation; group III (n=17) resection arthroplasty. Lymphocyte subpopulations were studied by laser flow cytofluorimetry method.
Results. In comparison of the cell immunity values in groups I, II, III with those of the control group there was observed the absence of subpopulation alterations in group I, as well as the elevation of relative content of D3+D8+ for normal content of D3+D4+ in group II; the elevation of both relative and absolute values of D3+D8+ while reduction of the values of D3+D4+ in group III. The content of activated T-lymphocytes was elevated in all three groups. A Kruskal-Wallis test to analyze 3 groups revealed significant difference between the groups (I, II, III) regarding the immunoregulatory index (CD4/CD3); (H-6,67; =0,035). There was statistically significant difference between groups I-III (p=0,012) and between groups II-III (p=0,011). Intergroup difference was also identified regarding D3+D4+ (%); (H-22,57; =0,0003). Statistically significant difference was determined between groups I-III (p=0,0002) and between groups II-III (p=0,0003).
Conclusions. The alterations in lymphocyte population composition can be considered as an informative marker of severe infection. The study of T-lymphocyte subpopulations -helpers (D3+D4+) and cytotoxic T-lymphocytes (D3+D8+)) can be used to reveal immuno-compromised patients. These values can be regarded as additional diagnostic tests to select the optimal surgical treatment of periprosthetic infection.

Keywords: periprosthetic infection, hip joint, cell-mediated immunity, -helpers (D3+D4+), cytotoxic T-lymphocytes (D3+D8+)
p. 276-283 of the original issue
References
  1. Kurtz SM, Lau EC, Son MS, Chang ET, Zimmerli W, Parvizi J. Are We winning or losing the battle with periprosthetic joint infection: trends in periprosthetic joint infection and mortality risk for the medicare population. J Arthroplasty. 2018 Oct;33(10):3238-45. doi: 10.1016/j.arth.2018.05.042
  2. Gomes LSM. Early Diagnosis of periprosthetic joint infection of the hip-current status, advances, and perspectives. Rev Bras Ortop (Sao Paulo). 2019 Jul;54(4):368-76. Published online 2019 Aug 20. doi: 10.1055/s-0039-1693138
  3. Izakovicova P, Borens O, Trampuz A. Periprosthetic joint infection: current concepts and outlook. EFORT Open Rev. 2019 Jul;4(7):482-94. Published online 2019 Jul 29. doi: 10.1302/2058-5241.4.180092
  4. Abblitt WP, Chan EW, Shinar AA. Risk of Periprosthetic joint infection in patients with multiple arthroplasties. J Arthroplasty. 2018 Mar;33(3):840-43. doi: 10.1016/j.arth.2017.10.024
  5. Winkler T, Trampuz A, Renz N, Perka C, Bozhkova SA. Classification and algorithm for diagnosis and treatment of hip prosthetic joint infection. Traumatology and Orthopedics of Russia. 2016;(1):33-45. doi: 10.21823/2311-2905-2016-0-1-33-45 (In Russ.)
  6. Saleh A, George J, Sultan AA, Samuel LT, Mont MA, Higuera-Rueda CA. The quality of diagnostic studies in periprosthetic joint infections: can we do better? J Arthroplasty. 2019 Nov;34(11):2737-43. doi: 10.1016/j.arth.2019.06.044
  7. Carli AV, Abdelbary H, Ahmadzai N, Cheng W, Shea B, Hutton B, Sniderman J, Philip Sanders BS, Esmaeilisaraji L, Skidmore B, Gauthier-Kwan OY, Bunting AC, Gauthier P, Crnic A, Logishetty K, Moher D, Fergusson D, Beaulé PE. Diagnostic accuracy of serum, synovial, and tissue testing for chronic periprosthetic joint infection after hip and knee replacements: a systematic review. J Bone Joint Surg Am. 2019 Apr 3;101(7):635-49. doi: 10.2106/JBJS.18.00632
  8. Saleh A, George J, Faour M, Klika AK, Higuera CA. Serum biomarkers in periprosthetic joint infections. Bone Joint Res. 2018 Jan;7(1):85-93. doi: 10.1302/2046-3758.71.BJR-2017-0323
  9. Gómez-García F, Espinoza-Mendoza RL. Whats new for the diagnosis of periprosthetic infections after the Philadelphia consensus? Acta Ortop Mex. 2019 Mar-Apr;33(2):127-35. [Article in Spanish; Abstract available in Spanish from the publisher]
  10. Chepeleva MV, Klyushin NM, Ermakov AM, Ababkov YuV. Interleukin-6 in predicting the course of postoperative period in patients with periprosthetic infection of the hip. Sib Nauch Med Zhurn. 2015;35(4):45-48. http://sibmed.net/article/360/8-4-2015.pdf (In Russ.)
  11. Heim CE, Vidlak D, Odvody J, Hartman CW, Garvin KL, Kielian T. Human prosthetic joint infections are associated with myeloid-derived suppressor cells (MDSCs): Implications for infection persistence. J Orthop Res. 2018 Jun;36(6):1605-13. doi: 10.1002/jor.23806
  12. Seebach E, Kubatzky KF. Chronic implant-related bone infections-can immune modulation be a therapeutic strategy? Front Immunol. 2019;10:1724. Published online 2019 Jul 23. doi: 10.3389/fimmu.2019.01724
  13. Preobrazhenskii PM, Kazemirskii AV, Goncharov MIu. Current views on diagnosing and treatment of patients with infection after the knee arthroplasty. Genii Ortopedii. 2016;(3):94-104. doi: 10.18019/1028-4427-2016-3-94-104 (In Russ)
  14. Lazarides AL, Vovos TJ, Reddy GB, Kildow BJ, Wellman SS, Jiranek WA, Seyler TM. Traditional laboratory markers hold low diagnostic utility for immunosuppressed patients with periprosthetic joint infections. J Arthroplasty. 2019 Jul;34(7):1441-45. doi: 10.1016/j.arth.2019.03.013
  15. Chuksina JuJu, Moscaletc OV, Jazdovskij VV, Eremin AV, Oshkukov SA. Clinical and immunological parallels in periprosthetic infection after total large joints arthroplasty. Kazan Med Zhurn. 2016;97(4):514-18. doi: 10.17750/KMJ2016-514 (In Russ.)
Address for correspondence:
640014, Russian Federation,
Kurgan, M. Ulyanova str., 6,
National Medical Research Center
of Traumatology and Orthopedics Named
after Academician G.A. Ilizarov of the Ministry
of Health of the Russian Federation,
tel. mobile: +7 912 838-42-49,
-mail: citoz@mail.ru,
Kuznecova Elena I.
Information about the authors:
Chepeleva Marina V., PhD, Senior Researcher, Scientific Clinical Laboratory of Microbiology and Immunology, National Medical Research Center of Traumatology and Orthopedics Named after Academician G.A. Ilizarov of the Ministry of Health of the Russian Federation, Kurgan, Russian Federation.
https://orcid.org/0000-0002-9731-115X
Kliushin Nicolay M., MD, professor, Head of the Clinic of Purulent osteology, National Medical Research Center of Traumatology and Orthopedics Named after Academician G.A. Ilizarov of the Ministry of Health the Russian Federation, Kurgan, Russian Federation.
https://orcid.org/0000-0002-1601- 9713
Ermakov Artem M., PhD, Traumatologist-Orthopedist, the Clinic of Purulent osteology, National Medical Research Center of Traumatology and Orthopedics Named after Academician G.A. Ilizarov of the Ministry of Health of the Russian Federation, Kurgan, Russian Federation.
https://orcid.org/0000-0002-5420-4637
Kuznecova Elena I., Junior Researcher, Scientific Clinical Laboratory of Microbiology and Immunology, National Medical Research Center of Traumatology and Orthopedics Named after Academician G.A. Ilizarov of the Ministry of Health of the Russian Federation, Kurgan, Russian Federation.
https://orcid.org/0000-0001-8022-5696
Contacts | ©Vitebsk State Medical University, 2007